About Us Strategy & Mission Our Values Our People Our Board Our Collaborations Contact Our Programmes Overview Pipeline C. difficile Infection Enterobacteriaceae ESKAPE Programme Clinical Trials Stewardship Compassionate Use Our Science Discuva Platform Publications Investors Investor Centre Press Releases Financial Reports & Filings Email Alerts Events & Presentations Share Price Data Analyst Coverage Corporate Governance Shareholder Meetings Careers
SMT19969 – Preclinical Safety And Pharmacokinetics Of A Novel Antimicrobial For Clostridium Difficile Infection SMT19969 – Preclinical Safety And Pharmacokinetics Of A Novel Antimicrobial For Clostridium Difficile Infection April 15, 2014 By CKD Digital
SMT19969 – Preclinical Safety And Pharmacokinetics Of A Novel Antimicrobial For Clostridium Difficile Infection
SMT19969 – Preclinical Safety And Pharmacokinetics Of A Novel Antimicrobial For Clostridium Difficile Infection April 15, 2014 By CKD Digital